Sign In

Login

Password

Forgot Password ? Sign Up

TLR4 (French Wikipedia)

Analysis of information sources in references of the Wikipedia article "TLR4" in French language version.

refsWebsite
Global rank French rank
56doi.org
2nd place
3rd place
55nih.gov
4th place
12th place
5issn.org
57th place
4th place
2ensembl.org
1,626th place
2,018th place
2nature.com
234th place
147th place
1frontiersin.org
4,679th place
1,649th place
1springer.com
274th place
223rd place
1aai.org
low place
low place
1rupress.org
low place
5,364th place
1uniprot.org
5,673rd place
low place
1ncku.edu.tw
low place
low place
1jle.com
low place
1,688th place
1acs.org
1,248th place
778th place
1nbcnews.com
137th place
607th place

aai.org

journals.aai.org

  • (en) Ian Sabroe, Elizabeth C. Jones, Lynne R. Usher et Moira K. B. Whyte, « Toll-Like Receptor (TLR)2 and TLR4 in Human Peripheral Blood Granulocytes: A Critical Role for Monocytes in Leukocyte Lipopolysaccharide Responses », The Journal of Immunology, vol. 168, no 9,‎ , p. 4701–4710 (ISSN 0022-1767 et 1550-6606, DOI 10.4049/jimmunol.168.9.4701, lire en ligne, consulté le )

acs.org

cen.acs.org

doi.org

dx.doi.org

  • (en) Céline Vaure et Yuanqing Liu, « A Comparative Review of Toll-Like Receptor 4 Expression and Functionality in Different Animal Species », Frontiers in Immunology, vol. 5,‎ (ISSN 1664-3224, DOI 10.3389/fimmu.2014.00316, lire en ligne, consulté le )
  • (en) Karsten Mahnke, Eva Becher, Paola Ricciardi-Castagnoli et Thomas A. Luger, « CD14 is Expressed by Subsets of Murine Dendritic Cells and Upregulated by Lipopolysaccharide », dans Dendritic Cells in Fundamental and Clinical Immunology: Volume 3, Springer US, , 145–159 p. (ISBN 978-1-4757-9966-8, DOI 10.1007/978-1-4757-9966-8_25, lire en ligne)
  • (en) Ian Sabroe, Elizabeth C. Jones, Lynne R. Usher et Moira K. B. Whyte, « Toll-Like Receptor (TLR)2 and TLR4 in Human Peripheral Blood Granulocytes: A Critical Role for Monocytes in Leukocyte Lipopolysaccharide Responses », The Journal of Immunology, vol. 168, no 9,‎ , p. 4701–4710 (ISSN 0022-1767 et 1550-6606, DOI 10.4049/jimmunol.168.9.4701, lire en ligne, consulté le )
  • (en) Huan Yang, Haichao Wang, Zhongliang Ju et Ahmed A. Ragab, « MD-2 is required for disulfide HMGB1–dependent TLR4 signaling », Journal of Experimental Medicine, vol. 212, no 1,‎ , p. 5–14 (ISSN 1540-9538 et 0022-1007, PMID 25559892, PMCID PMC4291531, DOI 10.1084/jem.20141318, lire en ligne, consulté le )
  • (en) Dianhua Jiang, Jiurong Liang, Juan Fan et Shuang Yu, « Regulation of lung injury and repair by Toll-like receptors and hyaluronan », Nature Medicine, vol. 11, no 11,‎ , p. 1173–1179 (ISSN 1546-170X, DOI 10.1038/nm1315, lire en ligne, consulté le )
  • (en) Hongliang Fang, Bing Ang, Xinyun Xu et Xiaohui Huang, « TLR4 is essential for dendritic cell activation and anti-tumor T-cell response enhancement by DAMPs released from chemically stressed cancer cells », Cellular & Molecular Immunology, vol. 11, no 2,‎ , p. 150–159 (ISSN 2042-0226, DOI 10.1038/cmi.2013.59, lire en ligne, consulté le )
  • « A comparative review of toll-like receptor 4 expression and functionality in different animal species », Frontiers in Immunology, vol. 5,‎ , p. 316 (PMID 25071777, PMCID 4090903, DOI 10.3389/fimmu.2014.00316)
  • « Innate immune pattern recognition: a cell biological perspective », Annual Review of Immunology, vol. 33,‎ , p. 257–90 (PMID 25581309, PMCID 5146691, DOI 10.1146/annurev-immunol-032414-112240)
  • « TLR-signaling and proinflammatory cytokines as drivers of tumorigenesis », Cytokine, vol. 89,‎ , p. 127–135 (PMID 26854213, DOI 10.1016/j.cyto.2016.01.021)
  • « The history of Toll-like receptors - redefining innate immunity », Nature Reviews. Immunology, vol. 13, no 6,‎ , p. 453–60 (PMID 23681101, DOI 10.1038/nri3446)
  • « LPS/TLR4 signal transduction pathway », Cytokine, vol. 42, no 2,‎ , p. 145–51 (PMID 18304834, DOI 10.1016/j.cyto.2008.01.006)
  • « Signal transduction by the lipopolysaccharide receptor, Toll-like receptor-4 », Immunology, vol. 113, no 2,‎ , p. 153–62 (PMID 15379975, PMCID 1782563, DOI 10.1111/j.1365-2567.2004.01976.x)
  • « Phylogenetic variation and polymorphism at the toll-like receptor 4 locus (TLR4) », Genome Biology, vol. 1, no 1,‎ , RESEARCH002 (PMID 11104518, PMCID 31919, DOI 10.1186/gb-2000-1-1-research002)
  • « Different selective pressures shape the evolution of Toll-like receptors in human and African great ape populations », Human Molecular Genetics, vol. 22, no 23,‎ , p. 4829–40 (PMID 23851028, PMCID 3820138, DOI 10.1093/hmg/ddt335)
  • « Evolutionary dynamics of human Toll-like receptors and their different contributions to host defense », PLoS Genetics, vol. 5, no 7,‎ , e1000562 (PMID 19609346, PMCID 2702086, DOI 10.1371/journal.pgen.1000562)
  • « The evolutionary history of TLR4 polymorphisms in Europe », Journal of Innate Immunity, vol. 4, no 2,‎ , p. 168–75 (PMID 21968286, DOI 10.1159/000329492)
  • « Monomeric recombinant MD-2 binds toll-like receptor 4 tightly and confers lipopolysaccharide responsiveness », The Journal of Biological Chemistry, vol. 277, no 26,‎ , p. 23427–32 (PMID 11976338, DOI 10.1074/jbc.M202554200)
  • « MD-2, a molecule that confers lipopolysaccharide responsiveness on Toll-like receptor 4 », The Journal of Experimental Medicine, vol. 189, no 11,‎ , p. 1777–82 (PMID 10359581, PMCID 2193086, DOI 10.1084/jem.189.11.1777)
  • « Triad3A, an E3 ubiquitin-protein ligase regulating Toll-like receptors », Nature Immunology, vol. 5, no 5,‎ , p. 495–502 (PMID 15107846, DOI 10.1038/ni1066)
  • « Toll-like receptor 3 mediates a more potent antiviral response than Toll-like receptor 4 », Journal of Immunology, vol. 170, no 7,‎ , p. 3565–71 (PMID 12646618, DOI 10.4049/jimmunol.170.7.3565)
  • « Murine TOLL-like receptor 4 confers lipopolysaccharide responsiveness as determined by activation of NF kappa B and expression of the inducible cyclooxygenase », The Journal of Biological Chemistry, vol. 275, no 44,‎ , p. 34035–40 (PMID 10952994, DOI 10.1074/jbc.M007386200)
  • « Mal (MyD88-adapter-like) is required for Toll-like receptor-4 signal transduction », Nature, vol. 413, no 6851,‎ , p. 78–83 (PMID 11544529, DOI 10.1038/35092578)
  • « Negative regulation of toll-like receptor-mediated signaling by Tollip », The Journal of Biological Chemistry, vol. 277, no 9,‎ , p. 7059–65 (PMID 11751856, DOI 10.1074/jbc.M109537200)
  • « Ni(II) interaction with a peptide model of the human TLR4 ectodomain », J Trace Elem Med Biol., vol. 44,‎ , p. 151-160 (PMID 28965571, DOI 10.1016/j.jtemb.2017.07.006)
  • « The Rab11a GTPase controls Toll-like receptor 4-induced activation of interferon regulatory factor-3 on phagosomes », Immunity, vol. 33, no 4,‎ , p. 583–96 (PMID 20933442, DOI 10.1016/j.immuni.2010.09.010)
  • « Single nucleotide polymorphisms of Toll-like receptors and susceptibility to infectious disease », The Lancet. Infectious Diseases, vol. 5, no 3,‎ , p. 156–64 (PMID 15766650, DOI 10.1016/S1473-3099(05)01308-3)
  • « Relevance of mutations in the TLR4 receptor in patients with gram-negative septic shock », Archives of Internal Medicine, vol. 162, no 9,‎ , p. 1028–32 (PMID 11996613, DOI 10.1001/archinte.162.9.1028)
  • « Polymorphisms of the toll-like receptor 2 and 4 genes are associated with faster progression and a more severe course of sepsis in critically ill patients », The Journal of International Medical Research, vol. 42, no 1,‎ , p. 93–110 (PMID 24366499, DOI 10.1177/0300060513504358)
  • « Fetuin-A acts as an endogenous ligand of TLR4 to promote lipid-induced insulin resistance », Nature Medicine, vol. 18, no 8,‎ , p. 1279-1285 (PMID 22842477, DOI 10.1038/nm.2851, lire en ligne)
  • « Toll-like receptor (TLR) polymorphisms in African children: Common TLR-4 variants predispose to severe malaria », Proceedings of the National Academy of Sciences of the United States of America, vol. 103, no 1,‎ , p. 177–82 (PMID 16371473, PMCID 1324982, DOI 10.1073/pnas.0506803102)
  • « Toll-like receptor 4 variant D299G induces features of neoplastic progression in Caco-2 intestinal cells and is associated with advanced human colon cancer », Gastroenterology, vol. 141, no 6,‎ , p. 2154–65 (PMID 21920464, PMCID 3268964, DOI 10.1053/j.gastro.2011.08.043)
  • « Binge alcohol drinking is associated with GABAA alpha2-regulated Toll-like receptor 4 (TLR4) expression in the central amygdala », Proceedings of the National Academy of Sciences of the United States of America, vol. 108, no 11,‎ , p. 4465–70 (PMID 21368176, PMCID 3060224, DOI 10.1073/pnas.1019020108)
  • « Involvement of TLR4/type I IL-1 receptor signaling in the induction of inflammatory mediators and cell death induced by ethanol in cultured astrocytes », Journal of Immunology, vol. 175, no 10,‎ , p. 6893–9 (PMID 16272348, DOI 10.4049/jimmunol.175.10.6893)
  • « Fragmented sleep accelerates tumor growth and progression through recruitment of tumor-associated macrophages and TLR4 signaling », Cancer Research, vol. 74, no 5,‎ , p. 1329–37 (PMID 24448240, PMCID 4247537, DOI 10.1158/0008-5472.CAN-13-3014)
  • « Interleukin-1 antagonizes morphine analgesia and underlies morphine tolerance », Pain, vol. 115, nos 1–2,‎ , p. 50–9 (PMID 15836969, DOI 10.1016/j.pain.2005.02.003)
  • « Dual regulation of mu opioid receptors in SK-N-SH neuroblastoma cells by morphine and interleukin-1β: evidence for opioid-immune crosstalk », Journal of Neuroimmunology, vol. 227, nos 1–2,‎ , p. 26–34 (PMID 20615556, PMCID 2942958, DOI 10.1016/j.jneuroim.2010.06.007)
  • « Mechanism of allodynia evoked by intrathecal morphine-3-glucuronide in mice », International Review of Neurobiology, vol. 85,‎ , p. 207–19 (ISBN 9780123748935, PMID 19607972, DOI 10.1016/S0074-7742(09)85016-2)
  • « Evidence that intrathecal morphine-3-glucuronide may cause pain enhancement via toll-like receptor 4/MD-2 and interleukin-1beta », Neuroscience, vol. 165, no 2,‎ , p. 569–83 (PMID 19833175, PMCID 2795035, DOI 10.1016/j.neuroscience.2009.10.011)
  • « Etanercept restores the antinociceptive effect of morphine and suppresses spinal neuroinflammation in morphine-tolerant rats », Anesthesia and Analgesia, vol. 112, no 2,‎ , p. 454–9 (PMID 21081778, DOI 10.1213/ANE.0b013e3182025b15)
  • « An IL-1 receptor antagonist blocks a morphine-induced attenuation of locomotor recovery after spinal cord injury », Brain, Behavior, and Immunity, vol. 25, no 2,‎ , p. 349–59 (PMID 20974246, PMCID 3025088, DOI 10.1016/j.bbi.2010.10.018)
  • « The "toll" of opioid-induced glial activation: improving the clinical efficacy of opioids by targeting glia », Trends in Pharmacological Sciences, vol. 30, no 11,‎ , p. 581–91 (PMID 19762094, PMCID 2783351, DOI 10.1016/j.tips.2009.08.002)
  • « Non-stereoselective reversal of neuropathic pain by naloxone and naltrexone: involvement of toll-like receptor 4 (TLR4) », The European Journal of Neuroscience, vol. 28, no 1,‎ , p. 20–9 (PMID 18662331, PMCID 2588470, DOI 10.1111/j.1460-9568.2008.06321.x)
  • « Proinflammatory cytokines oppose opioid-induced acute and chronic analgesia », Brain, Behavior, and Immunity, vol. 22, no 8,‎ , p. 1178–89 (PMID 18599265, PMCID 2783238, DOI 10.1016/j.bbi.2008.05.004)
  • « Possible involvement of toll-like receptor 4/myeloid differentiation factor-2 activity of opioid inactive isomers causes spinal proinflammation and related behavioral consequences », Neuroscience, vol. 167, no 3,‎ , p. 880–93 (PMID 20178837, PMCID 2854318, DOI 10.1016/j.neuroscience.2010.02.011)
  • « Ultra-low dose naloxone upregulates interleukin-10 expression and suppresses neuroinflammation in morphine-tolerant rat spinal cords », Behavioural Brain Research, vol. 207, no 1,‎ , p. 30–6 (PMID 19799935, DOI 10.1016/j.bbr.2009.09.034)
  • « Neuroscience: Making morphine work better », Nature, vol. 484, no 7395,‎ , p. 419 (DOI 10.1038/484419a)
  • Pascual M, Baliño P, Alfonso-Loeches S, Aragón CM, Guerri C, « Impact of TLR4 on behavioral and cognitive dysfunctions associated with alcohol-induced neuroinflammatory damage », Brain, Behavior, and Immunity, vol. 25 Suppl 1,‎ , S80-91 (PMID 21352907, DOI 10.1016/j.bbi.2011.02.012)
  • Kelley KW, Dantzer R, « Alcoholism and inflammation: neuroimmunology of behavioral and mood disorders », Brain, Behavior, and Immunity, vol. 25 Suppl 1,‎ , S13-20 (PMID 21193024, PMCID 4068736, DOI 10.1016/j.bbi.2010.12.013)
  • « Percutaneous penetration of 2,4-dichlorophenoxyacetic acid and 2,4-D dimethylamine salt in human volunteers », Journal of Toxicology and Environmental Health, vol. 36, no 3,‎ , p. 233–40 (PMID 1629934, DOI 10.1080/15287399209531634)
  • « Glucuronoxylomannan, a microbial compound, regulates expression of costimulatory molecules and production of cytokines in macrophages », The Journal of Infectious Diseases, vol. 191, no 1,‎ , p. 127–37 (PMID 15593014, DOI 10.1086/426511)
  • « Stereoselective action of (+)-morphine over (-)-morphine in attenuating the (-)-morphine-produced antinociception via the naloxone-sensitive sigma receptor in the mouse », European Journal of Pharmacology, vol. 571, nos 2–3,‎ , p. 145–51 (PMID 17617400, PMCID 2080825, DOI 10.1016/j.ejphar.2007.06.012)
  • « Phase 2 trial of eritoran tetrasodium (E5564), a toll-like receptor 4 antagonist, in patients with severe sepsis », Critical Care Medicine, vol. 38, no 1,‎ , p. 72–83 (PMID 19661804, DOI 10.1097/CCM.0b013e3181b07b78)
  • Hutchinson MR, Loram LC, Zhang Y, Shridhar M, Rezvani N, Berkelhammer D, Phipps S, Foster PS, Landgraf K, Falke JJ, Rice KC, Maier SF, Yin H, Watkins LR, « Evidence that tricyclic small molecules may possess toll-like receptor and myeloid differentiation protein 2 activity », Neuroscience, vol. 168, no 2,‎ , p. 551–63 (PMID 20381591, PMCID 2872682, DOI 10.1016/j.neuroscience.2010.03.067)
  • Jia ZJ, Wu FX, Huang QH, Liu JM, « [Toll-like receptor 4: the potential therapeutic target for neuropathic pain] », Zhongguo Yi Xue Ke Xue Yuan Xue Bao. Acta Academiae Medicinae Sinicae, vol. 34, no 2,‎ , p. 168–73 (PMID 22776604, DOI 10.3881/j.issn.1000-503X.2012.02.013)
  • Lan X, Han X, Li Q, Li Q, Gao Y, Cheng T, Wan J, Zhu W, Wang J, « Pinocembrin protects hemorrhagic brain primarily by inhibiting toll-like receptor 4 and reducing M1 phenotype microglia », Brain, behavior, and immunity, vol. 61,‎ , p. 326–339 (PMID 28007523, PMCID 5453178, DOI 10.1016/j.bbi.2016.12.012)
  • Hutchinson MR, Zhang Y, Shridhar M, Evans JH, Buchanan MM, Zhao TX, Slivka PF, Coats BD, Rezvani N, Wieseler J, Hughes TS, Landgraf KE, Chan S, Fong S, Phipps S, Falke JJ, Leinwand LA, Maier SF, Yin H, Rice KC, Watkins LR, « Evidence that opioids may have toll-like receptor 4 and MD-2 effects », Brain, Behavior, and Immunity, vol. 24, no 1,‎ , p. 83–95 (PMID 19679181, PMCID 2788078, DOI 10.1016/j.bbi.2009.08.004)

ensembl.org

May2017.archive.ensembl.org

frontiersin.org

  • (en) Céline Vaure et Yuanqing Liu, « A Comparative Review of Toll-Like Receptor 4 Expression and Functionality in Different Animal Species », Frontiers in Immunology, vol. 5,‎ (ISSN 1664-3224, DOI 10.3389/fimmu.2014.00316, lire en ligne, consulté le )

issn.org

portal.issn.org

  • (en) Céline Vaure et Yuanqing Liu, « A Comparative Review of Toll-Like Receptor 4 Expression and Functionality in Different Animal Species », Frontiers in Immunology, vol. 5,‎ (ISSN 1664-3224, DOI 10.3389/fimmu.2014.00316, lire en ligne, consulté le )
  • (en) Ian Sabroe, Elizabeth C. Jones, Lynne R. Usher et Moira K. B. Whyte, « Toll-Like Receptor (TLR)2 and TLR4 in Human Peripheral Blood Granulocytes: A Critical Role for Monocytes in Leukocyte Lipopolysaccharide Responses », The Journal of Immunology, vol. 168, no 9,‎ , p. 4701–4710 (ISSN 0022-1767 et 1550-6606, DOI 10.4049/jimmunol.168.9.4701, lire en ligne, consulté le )
  • (en) Huan Yang, Haichao Wang, Zhongliang Ju et Ahmed A. Ragab, « MD-2 is required for disulfide HMGB1–dependent TLR4 signaling », Journal of Experimental Medicine, vol. 212, no 1,‎ , p. 5–14 (ISSN 1540-9538 et 0022-1007, PMID 25559892, PMCID PMC4291531, DOI 10.1084/jem.20141318, lire en ligne, consulté le )
  • (en) Dianhua Jiang, Jiurong Liang, Juan Fan et Shuang Yu, « Regulation of lung injury and repair by Toll-like receptors and hyaluronan », Nature Medicine, vol. 11, no 11,‎ , p. 1173–1179 (ISSN 1546-170X, DOI 10.1038/nm1315, lire en ligne, consulté le )
  • (en) Hongliang Fang, Bing Ang, Xinyun Xu et Xiaohui Huang, « TLR4 is essential for dendritic cell activation and anti-tumor T-cell response enhancement by DAMPs released from chemically stressed cancer cells », Cellular & Molecular Immunology, vol. 11, no 2,‎ , p. 150–159 (ISSN 2042-0226, DOI 10.1038/cmi.2013.59, lire en ligne, consulté le )

jle.com

  • « Toll-like receptor 4 Asp299Gly/Thr399Ile polymorphisms are a risk factor for Candida bloodstream infection », European Cytokine Network, vol. 17, no 1,‎ , p. 29–34 (PMID 16613760, lire en ligne)

nature.com

  • (en) Dianhua Jiang, Jiurong Liang, Juan Fan et Shuang Yu, « Regulation of lung injury and repair by Toll-like receptors and hyaluronan », Nature Medicine, vol. 11, no 11,‎ , p. 1173–1179 (ISSN 1546-170X, DOI 10.1038/nm1315, lire en ligne, consulté le )
  • (en) Hongliang Fang, Bing Ang, Xinyun Xu et Xiaohui Huang, « TLR4 is essential for dendritic cell activation and anti-tumor T-cell response enhancement by DAMPs released from chemically stressed cancer cells », Cellular & Molecular Immunology, vol. 11, no 2,‎ , p. 150–159 (ISSN 2042-0226, DOI 10.1038/cmi.2013.59, lire en ligne, consulté le )

nbcnews.com

vitals.nbcnews.com

ncku.edu.tw

basicmed.med.ncku.edu.tw

nih.gov

ncbi.nlm.nih.gov

  • « Publications PubMed pour l'Homme », sur National Center for Biotechnology Information, U.S. National Library of Medicine
  • « Publications PubMed pour la Souris », sur National Center for Biotechnology Information, U.S. National Library of Medicine
  • (en) Huan Yang, Haichao Wang, Zhongliang Ju et Ahmed A. Ragab, « MD-2 is required for disulfide HMGB1–dependent TLR4 signaling », Journal of Experimental Medicine, vol. 212, no 1,‎ , p. 5–14 (ISSN 1540-9538 et 0022-1007, PMID 25559892, PMCID PMC4291531, DOI 10.1084/jem.20141318, lire en ligne, consulté le )
  • « A comparative review of toll-like receptor 4 expression and functionality in different animal species », Frontiers in Immunology, vol. 5,‎ , p. 316 (PMID 25071777, PMCID 4090903, DOI 10.3389/fimmu.2014.00316)
  • « Innate immune pattern recognition: a cell biological perspective », Annual Review of Immunology, vol. 33,‎ , p. 257–90 (PMID 25581309, PMCID 5146691, DOI 10.1146/annurev-immunol-032414-112240)
  • « Entrez Gene: TLR4 toll-like receptor 4 »
  • « TLR-signaling and proinflammatory cytokines as drivers of tumorigenesis », Cytokine, vol. 89,‎ , p. 127–135 (PMID 26854213, DOI 10.1016/j.cyto.2016.01.021)
  • « The history of Toll-like receptors - redefining innate immunity », Nature Reviews. Immunology, vol. 13, no 6,‎ , p. 453–60 (PMID 23681101, DOI 10.1038/nri3446)
  • « LPS/TLR4 signal transduction pathway », Cytokine, vol. 42, no 2,‎ , p. 145–51 (PMID 18304834, DOI 10.1016/j.cyto.2008.01.006)
  • « Signal transduction by the lipopolysaccharide receptor, Toll-like receptor-4 », Immunology, vol. 113, no 2,‎ , p. 153–62 (PMID 15379975, PMCID 1782563, DOI 10.1111/j.1365-2567.2004.01976.x)
  • « Evolution of the TIR, tolls and TLRs: functional inferences from computational biology », Current Topics in Microbiology and Immunology, vol. 270,‎ , p. 1–21 (PMID 12467241)
  • « Phylogenetic variation and polymorphism at the toll-like receptor 4 locus (TLR4) », Genome Biology, vol. 1, no 1,‎ , RESEARCH002 (PMID 11104518, PMCID 31919, DOI 10.1186/gb-2000-1-1-research002)
  • « Different selective pressures shape the evolution of Toll-like receptors in human and African great ape populations », Human Molecular Genetics, vol. 22, no 23,‎ , p. 4829–40 (PMID 23851028, PMCID 3820138, DOI 10.1093/hmg/ddt335)
  • « Evolutionary dynamics of human Toll-like receptors and their different contributions to host defense », PLoS Genetics, vol. 5, no 7,‎ , e1000562 (PMID 19609346, PMCID 2702086, DOI 10.1371/journal.pgen.1000562)
  • « The evolutionary history of TLR4 polymorphisms in Europe », Journal of Innate Immunity, vol. 4, no 2,‎ , p. 168–75 (PMID 21968286, DOI 10.1159/000329492)
  • « Monomeric recombinant MD-2 binds toll-like receptor 4 tightly and confers lipopolysaccharide responsiveness », The Journal of Biological Chemistry, vol. 277, no 26,‎ , p. 23427–32 (PMID 11976338, DOI 10.1074/jbc.M202554200)
  • « MD-2, a molecule that confers lipopolysaccharide responsiveness on Toll-like receptor 4 », The Journal of Experimental Medicine, vol. 189, no 11,‎ , p. 1777–82 (PMID 10359581, PMCID 2193086, DOI 10.1084/jem.189.11.1777)
  • « Triad3A, an E3 ubiquitin-protein ligase regulating Toll-like receptors », Nature Immunology, vol. 5, no 5,‎ , p. 495–502 (PMID 15107846, DOI 10.1038/ni1066)
  • « Toll-like receptor 3 mediates a more potent antiviral response than Toll-like receptor 4 », Journal of Immunology, vol. 170, no 7,‎ , p. 3565–71 (PMID 12646618, DOI 10.4049/jimmunol.170.7.3565)
  • « Murine TOLL-like receptor 4 confers lipopolysaccharide responsiveness as determined by activation of NF kappa B and expression of the inducible cyclooxygenase », The Journal of Biological Chemistry, vol. 275, no 44,‎ , p. 34035–40 (PMID 10952994, DOI 10.1074/jbc.M007386200)
  • « Mal (MyD88-adapter-like) is required for Toll-like receptor-4 signal transduction », Nature, vol. 413, no 6851,‎ , p. 78–83 (PMID 11544529, DOI 10.1038/35092578)
  • « Negative regulation of toll-like receptor-mediated signaling by Tollip », The Journal of Biological Chemistry, vol. 277, no 9,‎ , p. 7059–65 (PMID 11751856, DOI 10.1074/jbc.M109537200)
  • « Ni(II) interaction with a peptide model of the human TLR4 ectodomain », J Trace Elem Med Biol., vol. 44,‎ , p. 151-160 (PMID 28965571, DOI 10.1016/j.jtemb.2017.07.006)
  • « The Rab11a GTPase controls Toll-like receptor 4-induced activation of interferon regulatory factor-3 on phagosomes », Immunity, vol. 33, no 4,‎ , p. 583–96 (PMID 20933442, DOI 10.1016/j.immuni.2010.09.010)
  • « Single nucleotide polymorphisms of Toll-like receptors and susceptibility to infectious disease », The Lancet. Infectious Diseases, vol. 5, no 3,‎ , p. 156–64 (PMID 15766650, DOI 10.1016/S1473-3099(05)01308-3)
  • « Relevance of mutations in the TLR4 receptor in patients with gram-negative septic shock », Archives of Internal Medicine, vol. 162, no 9,‎ , p. 1028–32 (PMID 11996613, DOI 10.1001/archinte.162.9.1028)
  • « Polymorphisms of the toll-like receptor 2 and 4 genes are associated with faster progression and a more severe course of sepsis in critically ill patients », The Journal of International Medical Research, vol. 42, no 1,‎ , p. 93–110 (PMID 24366499, DOI 10.1177/0300060513504358)
  • « Fetuin-A acts as an endogenous ligand of TLR4 to promote lipid-induced insulin resistance », Nature Medicine, vol. 18, no 8,‎ , p. 1279-1285 (PMID 22842477, DOI 10.1038/nm.2851, lire en ligne)
  • « Toll-like receptor (TLR) polymorphisms in African children: Common TLR-4 variants predispose to severe malaria », Proceedings of the National Academy of Sciences of the United States of America, vol. 103, no 1,‎ , p. 177–82 (PMID 16371473, PMCID 1324982, DOI 10.1073/pnas.0506803102)
  • « Toll-like receptor 4 Asp299Gly/Thr399Ile polymorphisms are a risk factor for Candida bloodstream infection », European Cytokine Network, vol. 17, no 1,‎ , p. 29–34 (PMID 16613760, lire en ligne)
  • « Toll-like receptor 4 variant D299G induces features of neoplastic progression in Caco-2 intestinal cells and is associated with advanced human colon cancer », Gastroenterology, vol. 141, no 6,‎ , p. 2154–65 (PMID 21920464, PMCID 3268964, DOI 10.1053/j.gastro.2011.08.043)
  • « Binge alcohol drinking is associated with GABAA alpha2-regulated Toll-like receptor 4 (TLR4) expression in the central amygdala », Proceedings of the National Academy of Sciences of the United States of America, vol. 108, no 11,‎ , p. 4465–70 (PMID 21368176, PMCID 3060224, DOI 10.1073/pnas.1019020108)
  • « Involvement of TLR4/type I IL-1 receptor signaling in the induction of inflammatory mediators and cell death induced by ethanol in cultured astrocytes », Journal of Immunology, vol. 175, no 10,‎ , p. 6893–9 (PMID 16272348, DOI 10.4049/jimmunol.175.10.6893)
  • « Fragmented sleep accelerates tumor growth and progression through recruitment of tumor-associated macrophages and TLR4 signaling », Cancer Research, vol. 74, no 5,‎ , p. 1329–37 (PMID 24448240, PMCID 4247537, DOI 10.1158/0008-5472.CAN-13-3014)
  • « Interleukin-1 antagonizes morphine analgesia and underlies morphine tolerance », Pain, vol. 115, nos 1–2,‎ , p. 50–9 (PMID 15836969, DOI 10.1016/j.pain.2005.02.003)
  • « Dual regulation of mu opioid receptors in SK-N-SH neuroblastoma cells by morphine and interleukin-1β: evidence for opioid-immune crosstalk », Journal of Neuroimmunology, vol. 227, nos 1–2,‎ , p. 26–34 (PMID 20615556, PMCID 2942958, DOI 10.1016/j.jneuroim.2010.06.007)
  • « Mechanism of allodynia evoked by intrathecal morphine-3-glucuronide in mice », International Review of Neurobiology, vol. 85,‎ , p. 207–19 (ISBN 9780123748935, PMID 19607972, DOI 10.1016/S0074-7742(09)85016-2)
  • « Evidence that intrathecal morphine-3-glucuronide may cause pain enhancement via toll-like receptor 4/MD-2 and interleukin-1beta », Neuroscience, vol. 165, no 2,‎ , p. 569–83 (PMID 19833175, PMCID 2795035, DOI 10.1016/j.neuroscience.2009.10.011)
  • « Etanercept restores the antinociceptive effect of morphine and suppresses spinal neuroinflammation in morphine-tolerant rats », Anesthesia and Analgesia, vol. 112, no 2,‎ , p. 454–9 (PMID 21081778, DOI 10.1213/ANE.0b013e3182025b15)
  • « An IL-1 receptor antagonist blocks a morphine-induced attenuation of locomotor recovery after spinal cord injury », Brain, Behavior, and Immunity, vol. 25, no 2,‎ , p. 349–59 (PMID 20974246, PMCID 3025088, DOI 10.1016/j.bbi.2010.10.018)
  • « The "toll" of opioid-induced glial activation: improving the clinical efficacy of opioids by targeting glia », Trends in Pharmacological Sciences, vol. 30, no 11,‎ , p. 581–91 (PMID 19762094, PMCID 2783351, DOI 10.1016/j.tips.2009.08.002)
  • « Non-stereoselective reversal of neuropathic pain by naloxone and naltrexone: involvement of toll-like receptor 4 (TLR4) », The European Journal of Neuroscience, vol. 28, no 1,‎ , p. 20–9 (PMID 18662331, PMCID 2588470, DOI 10.1111/j.1460-9568.2008.06321.x)
  • « Proinflammatory cytokines oppose opioid-induced acute and chronic analgesia », Brain, Behavior, and Immunity, vol. 22, no 8,‎ , p. 1178–89 (PMID 18599265, PMCID 2783238, DOI 10.1016/j.bbi.2008.05.004)
  • « Possible involvement of toll-like receptor 4/myeloid differentiation factor-2 activity of opioid inactive isomers causes spinal proinflammation and related behavioral consequences », Neuroscience, vol. 167, no 3,‎ , p. 880–93 (PMID 20178837, PMCID 2854318, DOI 10.1016/j.neuroscience.2010.02.011)
  • « Ultra-low dose naloxone upregulates interleukin-10 expression and suppresses neuroinflammation in morphine-tolerant rat spinal cords », Behavioural Brain Research, vol. 207, no 1,‎ , p. 30–6 (PMID 19799935, DOI 10.1016/j.bbr.2009.09.034)
  • Pascual M, Baliño P, Alfonso-Loeches S, Aragón CM, Guerri C, « Impact of TLR4 on behavioral and cognitive dysfunctions associated with alcohol-induced neuroinflammatory damage », Brain, Behavior, and Immunity, vol. 25 Suppl 1,‎ , S80-91 (PMID 21352907, DOI 10.1016/j.bbi.2011.02.012)
  • Kelley KW, Dantzer R, « Alcoholism and inflammation: neuroimmunology of behavioral and mood disorders », Brain, Behavior, and Immunity, vol. 25 Suppl 1,‎ , S13-20 (PMID 21193024, PMCID 4068736, DOI 10.1016/j.bbi.2010.12.013)
  • « Percutaneous penetration of 2,4-dichlorophenoxyacetic acid and 2,4-D dimethylamine salt in human volunteers », Journal of Toxicology and Environmental Health, vol. 36, no 3,‎ , p. 233–40 (PMID 1629934, DOI 10.1080/15287399209531634)
  • « Glucuronoxylomannan, a microbial compound, regulates expression of costimulatory molecules and production of cytokines in macrophages », The Journal of Infectious Diseases, vol. 191, no 1,‎ , p. 127–37 (PMID 15593014, DOI 10.1086/426511)
  • « Stereoselective action of (+)-morphine over (-)-morphine in attenuating the (-)-morphine-produced antinociception via the naloxone-sensitive sigma receptor in the mouse », European Journal of Pharmacology, vol. 571, nos 2–3,‎ , p. 145–51 (PMID 17617400, PMCID 2080825, DOI 10.1016/j.ejphar.2007.06.012)
  • « Phase 2 trial of eritoran tetrasodium (E5564), a toll-like receptor 4 antagonist, in patients with severe sepsis », Critical Care Medicine, vol. 38, no 1,‎ , p. 72–83 (PMID 19661804, DOI 10.1097/CCM.0b013e3181b07b78)
  • Hutchinson MR, Loram LC, Zhang Y, Shridhar M, Rezvani N, Berkelhammer D, Phipps S, Foster PS, Landgraf K, Falke JJ, Rice KC, Maier SF, Yin H, Watkins LR, « Evidence that tricyclic small molecules may possess toll-like receptor and myeloid differentiation protein 2 activity », Neuroscience, vol. 168, no 2,‎ , p. 551–63 (PMID 20381591, PMCID 2872682, DOI 10.1016/j.neuroscience.2010.03.067)
  • Jia ZJ, Wu FX, Huang QH, Liu JM, « [Toll-like receptor 4: the potential therapeutic target for neuropathic pain] », Zhongguo Yi Xue Ke Xue Yuan Xue Bao. Acta Academiae Medicinae Sinicae, vol. 34, no 2,‎ , p. 168–73 (PMID 22776604, DOI 10.3881/j.issn.1000-503X.2012.02.013)
  • Lan X, Han X, Li Q, Li Q, Gao Y, Cheng T, Wan J, Zhu W, Wang J, « Pinocembrin protects hemorrhagic brain primarily by inhibiting toll-like receptor 4 and reducing M1 phenotype microglia », Brain, behavior, and immunity, vol. 61,‎ , p. 326–339 (PMID 28007523, PMCID 5453178, DOI 10.1016/j.bbi.2016.12.012)
  • Hutchinson MR, Zhang Y, Shridhar M, Evans JH, Buchanan MM, Zhao TX, Slivka PF, Coats BD, Rezvani N, Wieseler J, Hughes TS, Landgraf KE, Chan S, Fong S, Phipps S, Falke JJ, Leinwand LA, Maier SF, Yin H, Rice KC, Watkins LR, « Evidence that opioids may have toll-like receptor 4 and MD-2 effects », Brain, Behavior, and Immunity, vol. 24, no 1,‎ , p. 83–95 (PMID 19679181, PMCID 2788078, DOI 10.1016/j.bbi.2009.08.004)

rupress.org

springer.com

link.springer.com

  • (en) Karsten Mahnke, Eva Becher, Paola Ricciardi-Castagnoli et Thomas A. Luger, « CD14 is Expressed by Subsets of Murine Dendritic Cells and Upregulated by Lipopolysaccharide », dans Dendritic Cells in Fundamental and Clinical Immunology: Volume 3, Springer US, , 145–159 p. (ISBN 978-1-4757-9966-8, DOI 10.1007/978-1-4757-9966-8_25, lire en ligne)

uniprot.org